Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 32, Issue 2, Pages 238-245Publisher
INFORMA HEALTHCARE
DOI: 10.3109/08923970903222355
Keywords
-
Categories
Ask authors/readers for more resources
Boosting an effective immune response against established tumors remains a difficult challenge. This study shows the combination of 1) adoptive cell transfer using CD25 depleted splenocytes co-cultured with irradiated tumor cells, and 2) antibody injection therapy using CTLA4 blockade, the elimination of Treg and OX40, which together could eradicate an established MethA tumor in over 50% of the BALB/c mice. Each element of the protocol was shown to be necessary, as elimination of any factor except anti-CD25 antibody injection failed to eradicate the tumor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
© Peeref 2019-2024. All rights reserved.